Unknown

Dataset Information

0

Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews.


ABSTRACT: Re-emerging human adenovirus type 55 (HAdV55) has become a significant threat to public health due to its widespread circulation and the association with severe pneumonia, but an effective anti-HAdV55 agent remains unavailable. Herein, we report the generation of macaque-derived, human-like monoclonal antibodies (mAbs) protecting against HAdV55 infection with high potency. Using fluorophore-labelled HAdV55 virions as probes, we isolated specific memory B cells from rhesus macaques (Macaca mulatta) that were immunized twice with an experimental vaccine based on E1-, E3-deleted, replication-incompetent HAdV55. We cloned a total of 19 neutralizing mAbs, nine of which showed half-maximal inhibitory concentrations below 1.0 ng/ml. These mAbs recognized the hyper-variable-region (HVR) 1, 2, or 7 of viral hexon protein, or the fibre knob. In transgenic mice expressing human desmoglein-2, the major cellular receptor for HAdV55, a single intraperitoneal injection with hexon-targeting mAbs efficiently prevented HAdV55 infection, and mAb 29C12 showed protection at a dose as low as 0.004 mg/kg. Fibre-targeting mAb 28E8, however, showed protection only at a dose up to 12.5 mg/kg. In tree shrews that are permissive for HAdV55 infection and disease, mAb 29C12 effectively prevented HAdV55-caused pneumonia. Further analysis revealed that fibre-targeting mAbs blocked the attachment of HAdV55 to host cells, whereas hexon-targeting mAbs, regardless of their targeting HVRs, mainly functioned at post-attachment stage via inhibiting viral endosomal escape. Our results indicate that hexon-targeting mAbs have great anti-HAdV55 activities and warrant pre-clinical and clinical evaluation.

SUBMITTER: Liu X 

PROVIDER: S-EPMC10836490 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews.

Liu Xinglong X   Li Zhengfeng Z   Li Xiao X   Zhang Xiaoyan X   Zheng Yali Y   Su Wan W   Feng Ying Y   Liu Yutong Y   Wu Weixuan W   Sun Xikui X   Wang Nana N   Ye Xianmiao X   Zhou Zhichao Z   Liu Wenkuan W   He Jun J   Wang Wei W   Qu Linbing L   Zhou Rong R   Chen Ling L   Feng Liqiang L  

Emerging microbes & infections 20240201 1


Re-emerging human adenovirus type 55 (HAdV55) has become a significant threat to public health due to its widespread circulation and the association with severe pneumonia, but an effective anti-HAdV55 agent remains unavailable. Herein, we report the generation of macaque-derived, human-like monoclonal antibodies (mAbs) protecting against HAdV55 infection with high potency. Using fluorophore-labelled HAdV55 virions as probes, we isolated specific memory B cells from rhesus macaques (<i>Macaca mul  ...[more]

Similar Datasets

| S-EPMC8040518 | biostudies-literature
| S-EPMC6286715 | biostudies-literature
| S-EPMC7365452 | biostudies-literature
| S-EPMC5520307 | biostudies-literature
| S-EPMC8716168 | biostudies-literature
| S-EPMC7386402 | biostudies-literature
| S-EPMC11457859 | biostudies-literature
| S-EPMC4867612 | biostudies-literature
| S-EPMC8190289 | biostudies-literature
| S-EPMC7144216 | biostudies-literature